Loading...
Bionano Genomics, Inc.
BNGO•NASDAQ
Healthcare
Medical - Diagnostics & Research
$3.38
$-0.08(-2.31%)
Bionano Genomics, Inc. (BNGO) AI-Powered Stock Analysis
See how Bionano Genomics, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerBionano Genomics, Inc. (BNGO) Stock Overall Grade
Bionano Genomics, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Bionano Genomics, Inc.'s overall stock rating.
Forecast
B+Score
73/100Financial Growth
BScore
60/100Fundamental Growth
C+Score
56/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
70/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Bionano Genomics, Inc. (BNGO) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 73/100 (B+), reflecting high confidence in its potential. Financial Growth (60/100, B) and Fundamental Growth (56/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Bionano Genomics, Inc. stock grade, including financials, comparisons, and forecasts.